# Hyagen Medical Participates in PepMed 2026 to Discuss Regulatory Clarity in Stem Cell Therapy

Page: https://stenobird.com/podcast/global-economic-press-7086730/hyagen-medical-participates-in-pepmed-2026-to-discuss-regulatory-clarity-in-stem-cell-therapy
Text version: https://stenobird.com/podcast/global-economic-press-7086730/hyagen-medical-participates-in-pepmed-2026-to-discuss-regulatory-clarity-in-stem-cell-therapy.md
Podcast: [Global Economic Press](https://stenobird.com/podcast/global-economic-press-7086730)
Published: 2026-09-22T21:30:50+00:00
Episode link: https://global-economic-press.podbean.com/e/hyagen-medical-participates-in-pepmed-2026-to-discuss-regulatory-clarity-in-stem-cell-therapy/
Audio file: https://mcdn.podbean.com/mf/web/hq5yy5pxuwmfie3z/press_release_14838_1790112650.mp3
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/global-economic-press-7086730/episodes/hyagen-medical-participates-in-pepmed-2026-to-discuss-regulatory-clarity-in-stem-cell-therapy
Duration seconds: 439

## Resource

In this episode of Global Economic Press, Alex Brady discusses the participation of Hyagen Medical in the PepMed 2026 Regenerative Health World Congress, focusing on regulatory clarity in stem cell therapy. Hyagen Medical, a company dedicated to advancing regulatory clarity and responsible education in regenerative medicine, was represented by its founder and president, Chuck Meeker, Ph.D., Esq. The event featured a panel titled "Beyond the Headlines: Can America Become the Stem Cell Capital of the World?" which explored the potential for the United States to lead in stem cell therapy through improved classification, domestic access, and regulatory understanding. For more information about Hyagen Medical, visit their website at Hyagen Medical. The panel discussion, moderated by Travis Smith, D.O., FACEP, from the Department of Health and Human Services, brought together experts from various fields, including science, clinical practice, and health care entrepreneurship. The conversation highlighted the importance of understanding product classification, regulatory pathways, and responsible communication in regenerative medicine. Hyagen Medical emphasized its compliance-first philosophy, advocating for clinicians to fully understand the products they work with before communicating with patients. The event underscored the need for greater clarity and understanding in the field, which can help clinicians make informed decisions, provide patients with context, and support responsible innovation and investment in the United States.

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/global-economic-press-7086730/episodes/hyagen-medical-participates-in-pepmed-2026-to-discuss-regulatory-clarity-in-stem-cell-therapy/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/global-economic-press-7086730/hyagen-medical-participates-in-pepmed-2026-to-discuss-regulatory-clarity-in-stem-cell-therapy.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.